south manchester healthcare limited
south manchester healthcare limited Company Information
Company Number
03502432
Next Accounts
Dec 2025
Industry
Other personal service activities n.e.c.
Shareholders
south manchester healthcare (holdings) ltd
Group Structure
View All
Contact
Registered Address
third floor broad quay house, prince street, bristol, BS1 4DJ
Website
-south manchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of SOUTH MANCHESTER HEALTHCARE LIMITED at £52m based on a Turnover of £46.8m and 1.11x industry multiple (adjusted for size and gross margin).
south manchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of SOUTH MANCHESTER HEALTHCARE LIMITED at £44.6m based on an EBITDA of £6.8m and a 6.54x industry multiple (adjusted for size and gross margin).
south manchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of SOUTH MANCHESTER HEALTHCARE LIMITED at £41.4m based on Net Assets of £18.3m and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
South Manchester Healthcare Limited Overview
South Manchester Healthcare Limited is a live company located in bristol, BS1 4DJ with a Companies House number of 03502432. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in February 1998, it's largest shareholder is south manchester healthcare (holdings) ltd with a 100% stake. South Manchester Healthcare Limited is a mature, large sized company, Pomanda has estimated its turnover at £46.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
South Manchester Healthcare Limited Health Check
Pomanda's financial health check has awarded South Manchester Healthcare Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
3 Weak
Size
annual sales of £46.8m, make it larger than the average company (£858.2k)
£46.8m - South Manchester Healthcare Limited
£858.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a similar rate (8.3%)
9% - South Manchester Healthcare Limited
8.3% - Industry AVG
Production
with a gross margin of 17%, this company has a higher cost of product (38.6%)
17% - South Manchester Healthcare Limited
38.6% - Industry AVG
Profitability
an operating margin of 14.6% make it more profitable than the average company (5.8%)
14.6% - South Manchester Healthcare Limited
5.8% - Industry AVG
Employees
with 623 employees, this is above the industry average (14)
- South Manchester Healthcare Limited
14 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- South Manchester Healthcare Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £75.2k, this is equally as efficient (£75.3k)
- South Manchester Healthcare Limited
£75.3k - Industry AVG
Debtor Days
it gets paid by customers after 3 days, this is earlier than average (28 days)
3 days - South Manchester Healthcare Limited
28 days - Industry AVG
Creditor Days
its suppliers are paid after 11 days, this is quicker than average (37 days)
11 days - South Manchester Healthcare Limited
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - South Manchester Healthcare Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 46 weeks, this is less cash available to meet short term requirements (58 weeks)
46 weeks - South Manchester Healthcare Limited
58 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.7%, this is a lower level of debt than the average (37.3%)
19.7% - South Manchester Healthcare Limited
37.3% - Industry AVG
SOUTH MANCHESTER HEALTHCARE LIMITED financials
South Manchester Healthcare Limited's latest turnover from March 2024 is £46.8 million and the company has net assets of £18.3 million. According to their latest financial statements, we estimate that South Manchester Healthcare Limited has 623 employees and maintains cash reserves of £1.9 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 46,845,000 | 42,949,000 | 41,177,000 | 35,778,000 | 35,848,000 | 31,956,000 | 31,830,000 | 31,203,000 | 27,294,000 | 27,003,000 | 25,405,000 | 24,899,000 | 24,865,000 | 21,816,000 | 20,699,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 38,881,000 | 33,729,000 | 30,643,000 | 30,668,000 | 31,543,000 | 28,364,000 | 28,729,000 | 27,814,000 | 23,690,000 | 23,371,000 | 21,949,000 | 21,629,000 | 21,250,000 | 20,835,000 | 19,108,000 |
| Gross Profit | 7,964,000 | 9,220,000 | 10,534,000 | 5,110,000 | 4,305,000 | 3,592,000 | 3,101,000 | 3,389,000 | 3,604,000 | 3,632,000 | 3,456,000 | 3,270,000 | 3,615,000 | 981,000 | 1,591,000 |
| Admin Expenses | 1,141,000 | 1,290,000 | 844,000 | 806,000 | 814,000 | 582,000 | 782,000 | 705,000 | 835,000 | 707,000 | 716,000 | 663,000 | 726,000 | 1,071,000 | 744,000 |
| Operating Profit | 6,823,000 | 7,930,000 | 9,690,000 | 4,304,000 | 3,491,000 | 3,010,000 | 2,319,000 | 2,684,000 | 2,769,000 | 2,925,000 | 2,740,000 | 2,607,000 | 2,889,000 | -90,000 | 847,000 |
| Interest Payable | 271,000 | 478,000 | 666,000 | 839,000 | 1,085,000 | 1,166,000 | 1,284,000 | 1,413,000 | 1,540,000 | 1,645,000 | 2,749,000 | 4,404,000 | 4,641,000 | 4,932,000 | 5,174,000 |
| Interest Receivable | 1,628,000 | 1,680,000 | 1,707,000 | 2,046,000 | 2,578,000 | 3,042,000 | 3,437,000 | 3,826,000 | 4,294,000 | 4,807,000 | 5,026,000 | 5,665,000 | 5,839,000 | 8,709,000 | 8,490,000 |
| Pre-Tax Profit | 8,180,000 | 9,132,000 | 10,731,000 | 5,511,000 | 4,984,000 | 4,886,000 | 4,472,000 | 5,097,000 | 5,523,000 | 6,087,000 | 5,017,000 | 3,868,000 | 4,087,000 | 3,687,000 | 4,163,000 |
| Tax | -2,204,000 | -1,847,000 | -2,756,000 | -1,576,000 | -3,379,000 | -145,000 | -1,313,000 | -1,573,000 | -594,000 | -2,053,000 | 198,000 | -729,000 | -478,000 | -544,000 | -1,702,000 |
| Profit After Tax | 5,976,000 | 7,285,000 | 7,975,000 | 3,935,000 | 1,605,000 | 4,741,000 | 3,159,000 | 3,524,000 | 4,929,000 | 4,034,000 | 5,215,000 | 3,139,000 | 3,609,000 | 3,143,000 | 2,461,000 |
| Dividends Paid | 3,353,000 | 4,801,000 | 3,353,000 | 3,295,000 | 2,756,000 | 2,914,000 | 0 | 4,468,000 | 5,625,000 | 5,320,000 | 6,634,000 | 2,508,000 | 3,222,000 | 1,505,000 | 1,498,000 |
| Retained Profit | 2,623,000 | 2,484,000 | 4,622,000 | 640,000 | -1,151,000 | 1,827,000 | 3,159,000 | -944,000 | -696,000 | -1,286,000 | -1,419,000 | 631,000 | 387,000 | 1,638,000 | 963,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Number Of Employees | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 5 | 6 | 5 | 5 | ||||
| EBITDA* | 6,823,000 | 7,930,000 | 9,690,000 | 4,304,000 | 3,491,000 | 3,010,000 | 2,319,000 | 2,684,000 | 2,769,000 | 2,925,000 | 2,740,000 | 2,607,000 | 2,889,000 | -90,000 | 847,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,284,000 |
| Debtors (Due After 1 year) | 17,956,000 | 19,551,000 | 21,062,000 | 17,228,000 | 23,847,000 | 30,482,000 | 37,205,000 | 43,264,000 | 48,959,000 | 55,010,000 | 62,362,000 | 67,311,000 | 72,419,000 | 77,692,000 | 79,412,000 |
| Total Fixed Assets | 17,956,000 | 19,551,000 | 21,062,000 | 17,228,000 | 23,847,000 | 30,482,000 | 37,205,000 | 43,264,000 | 48,959,000 | 55,010,000 | 62,362,000 | 67,311,000 | 72,419,000 | 77,692,000 | 82,696,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 390,000 | 279,000 | 1,000 | 2,000 | 140,000 | 49,000 | 46,000 | 68,000 | 84,000 | 474,000 | 64,000 | 5,161,000 | 4,107,000 | 2,355,000 | 1,184,000 |
| Group Debtors | 1,000 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,558,000 | 2,094,000 | 2,104,000 | 7,363,000 | 7,437,000 | 6,769,000 | 6,351,000 | 6,394,000 | 6,188,000 | 7,416,000 | 6,805,000 | 601,000 | 111,000 | 574,000 | 477,000 |
| Cash | 1,859,000 | 4,039,000 | 10,463,000 | 10,413,000 | 9,923,000 | 9,606,000 | 8,821,000 | 8,051,000 | 7,765,000 | 6,892,000 | 5,980,000 | 8,288,000 | 6,689,000 | 6,530,000 | 5,892,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 4,808,000 | 6,413,000 | 12,569,000 | 17,779,000 | 17,500,000 | 16,424,000 | 15,218,000 | 14,513,000 | 14,037,000 | 14,782,000 | 12,849,000 | 14,050,000 | 10,907,000 | 9,459,000 | 7,553,000 |
| total assets | 22,764,000 | 25,964,000 | 33,631,000 | 35,007,000 | 41,347,000 | 46,906,000 | 52,423,000 | 57,777,000 | 62,996,000 | 69,792,000 | 75,211,000 | 81,361,000 | 83,326,000 | 87,151,000 | 90,249,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,213,000 | 612,000 | 652,000 | 2,000 | 187,000 | 33,000 | 255,000 | 39,000 | 142,000 | 360,000 | 71,000 | 17,000 | 208,000 | 583,000 | 919,000 |
| Group/Directors Accounts | 67,000 | 94,000 | 92,000 | 56,000 | 116,000 | 63,000 | 36,000 | 54,000 | 72,000 | 39,000 | 35,000 | 19,000 | 0 | 0 | 0 |
| other short term finances | 0 | 6,174,000 | 6,754,000 | 6,278,000 | 5,848,000 | 5,439,000 | 5,059,000 | 4,712,000 | 4,366,000 | 4,075,000 | 3,792,000 | 3,518,000 | 3,172,000 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 809,000 | 883,000 | 562,000 | 1,515,000 | 1,748,000 | 1,798,000 | 1,919,000 | 2,901,000 | 2,121,000 | 2,132,000 | 1,439,000 | 1,564,000 | 1,393,000 | 5,040,000 | 3,749,000 |
| total current liabilities | 2,089,000 | 7,763,000 | 8,060,000 | 7,851,000 | 7,899,000 | 7,333,000 | 7,269,000 | 7,706,000 | 6,701,000 | 6,606,000 | 5,337,000 | 5,118,000 | 4,773,000 | 5,623,000 | 4,668,000 |
| loans | 0 | 0 | 9,737,000 | 16,827,000 | 23,271,000 | 29,064,000 | 34,859,000 | 40,235,000 | 44,892,000 | 48,729,000 | 6,174,000 | 6,174,000 | 6,326,000 | 6,627,000 | 6,627,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,000 | 28,000 | 28,000 | 22,000 | 0 | 0 | 368,000 | 369,000 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46,087,000 | 50,201,000 | 53,719,000 | 56,890,000 | 63,124,000 |
| provisions | 2,405,000 | 2,554,000 | 2,657,000 | 2,061,000 | 2,688,000 | 1,834,000 | 3,742,000 | 4,186,000 | 4,736,000 | 6,650,000 | 8,092,000 | 8,950,000 | 8,221,000 | 7,743,000 | 7,199,000 |
| total long term liabilities | 2,405,000 | 2,554,000 | 12,394,000 | 18,888,000 | 25,959,000 | 30,898,000 | 38,601,000 | 44,433,000 | 49,656,000 | 55,407,000 | 60,375,000 | 65,325,000 | 68,266,000 | 71,628,000 | 77,319,000 |
| total liabilities | 4,494,000 | 10,317,000 | 20,454,000 | 26,739,000 | 33,858,000 | 38,231,000 | 45,870,000 | 52,139,000 | 56,357,000 | 62,013,000 | 65,712,000 | 70,443,000 | 73,039,000 | 77,251,000 | 81,987,000 |
| net assets | 18,270,000 | 15,647,000 | 13,177,000 | 8,268,000 | 7,489,000 | 8,675,000 | 6,553,000 | 5,638,000 | 6,639,000 | 7,779,000 | 9,499,000 | 10,918,000 | 10,287,000 | 9,900,000 | 8,262,000 |
| total shareholders funds | 18,270,000 | 15,647,000 | 13,177,000 | 8,268,000 | 7,489,000 | 8,675,000 | 6,553,000 | 5,638,000 | 6,639,000 | 7,779,000 | 9,499,000 | 10,918,000 | 10,287,000 | 9,900,000 | 8,262,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 6,823,000 | 7,930,000 | 9,690,000 | 4,304,000 | 3,491,000 | 3,010,000 | 2,319,000 | 2,684,000 | 2,769,000 | 2,925,000 | 2,740,000 | 2,607,000 | 2,889,000 | -90,000 | 847,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -2,204,000 | -1,847,000 | -2,756,000 | -1,576,000 | -3,379,000 | -145,000 | -1,313,000 | -1,573,000 | -594,000 | -2,053,000 | 198,000 | -729,000 | -478,000 | -544,000 | -1,702,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -1,020,000 | -1,243,000 | -1,426,000 | -6,830,000 | -5,876,000 | -6,302,000 | -6,124,000 | -5,505,000 | -7,669,000 | -6,331,000 | -3,842,000 | -3,564,000 | -3,984,000 | -452,000 | 81,073,000 |
| Creditors | 601,000 | -40,000 | 650,000 | -185,000 | 154,000 | -222,000 | 216,000 | -103,000 | -218,000 | 289,000 | 54,000 | -191,000 | -375,000 | -336,000 | 919,000 |
| Accruals and Deferred Income | -74,000 | 321,000 | -953,000 | -233,000 | -50,000 | -121,000 | -994,000 | 764,000 | -11,000 | 699,000 | -103,000 | 171,000 | -4,015,000 | 1,290,000 | 4,118,000 |
| Deferred Taxes & Provisions | -149,000 | -103,000 | 596,000 | -627,000 | 854,000 | -1,908,000 | -444,000 | -550,000 | -1,914,000 | -1,442,000 | -858,000 | 729,000 | 478,000 | 544,000 | 7,199,000 |
| Cash flow from operations | 6,017,000 | 7,504,000 | 8,653,000 | 8,513,000 | 6,946,000 | 6,916,000 | 5,908,000 | 6,727,000 | 7,701,000 | 6,749,000 | 5,873,000 | 6,151,000 | 2,483,000 | 1,316,000 | -69,692,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,284,000 | 3,284,000 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -27,000 | 2,000 | 36,000 | -60,000 | 53,000 | 27,000 | -18,000 | -18,000 | 33,000 | 4,000 | 16,000 | 19,000 | 0 | 0 | 0 |
| Other Short Term Loans | -6,174,000 | -580,000 | 476,000 | 430,000 | 409,000 | 380,000 | 347,000 | 346,000 | 291,000 | 283,000 | 274,000 | 346,000 | 3,172,000 | 0 | 0 |
| Long term loans | 0 | -9,737,000 | -7,090,000 | -6,444,000 | -5,793,000 | -5,795,000 | -5,376,000 | -4,657,000 | -3,837,000 | 42,555,000 | 0 | -152,000 | -301,000 | 0 | 6,627,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -46,087,000 | -4,114,000 | -3,518,000 | -3,171,000 | -6,234,000 | 63,124,000 |
| share issue | |||||||||||||||
| interest | 1,357,000 | 1,202,000 | 1,041,000 | 1,207,000 | 1,493,000 | 1,876,000 | 2,153,000 | 2,413,000 | 2,754,000 | 3,162,000 | 2,277,000 | 1,261,000 | 1,198,000 | 3,777,000 | 3,316,000 |
| cash flow from financing | -4,844,000 | -9,127,000 | -5,250,000 | -4,728,000 | -3,873,000 | -3,217,000 | -5,138,000 | -1,973,000 | -1,203,000 | -517,000 | -1,547,000 | -2,044,000 | 898,000 | -2,457,000 | 80,366,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -2,180,000 | -6,424,000 | 50,000 | 490,000 | 317,000 | 785,000 | 770,000 | 286,000 | 873,000 | 912,000 | -2,308,000 | 1,599,000 | 159,000 | 638,000 | 5,892,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -2,180,000 | -6,424,000 | 50,000 | 490,000 | 317,000 | 785,000 | 770,000 | 286,000 | 873,000 | 912,000 | -2,308,000 | 1,599,000 | 159,000 | 638,000 | 5,892,000 |
south manchester healthcare limited Credit Report and Business Information
South Manchester Healthcare Limited Competitor Analysis
Perform a competitor analysis for south manchester healthcare limited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other large companies, companies in BS1 area or any other competitors across 12 key performance metrics.
south manchester healthcare limited Ownership
SOUTH MANCHESTER HEALTHCARE LIMITED group structure
South Manchester Healthcare Limited has no subsidiary companies.
Ultimate parent company
SEMPERIAN PPP INVESTMENT PARTNERS HOLDIN
#0062968
2 parents
SOUTH MANCHESTER HEALTHCARE LIMITED
03502432
south manchester healthcare limited directors
South Manchester Healthcare Limited currently has 5 directors. The longest serving directors include Mrs Gaynor Birley-Smith (Oct 2018) and Mr Benjamin Watson (Dec 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Gaynor Birley-Smith | England | 58 years | Oct 2018 | - | Director |
| Mr Benjamin Watson | England | 39 years | Dec 2018 | - | Director |
| Mr Alan Ritchie | United Kingdom | 57 years | Aug 2019 | - | Director |
| Mr Alan Ritchie | England | 57 years | Aug 2019 | - | Director |
| Mr Louis Falero | England | 47 years | Jun 2023 | - | Director |
P&L
March 2024turnover
46.8m
+9%
operating profit
6.8m
-14%
gross margin
17.1%
-20.81%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
18.3m
+0.17%
total assets
22.8m
-0.12%
cash
1.9m
-0.54%
net assets
Total assets minus all liabilities
south manchester healthcare limited company details
company number
03502432
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
February 1998
age
27
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
glancechange limited (March 1998)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
third floor broad quay house, prince street, bristol, BS1 4DJ
Bank
-
Legal Advisor
-
south manchester healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 13 charges/mortgages relating to south manchester healthcare limited. Currently there are 0 open charges and 13 have been satisfied in the past.
south manchester healthcare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SOUTH MANCHESTER HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
south manchester healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
